Evidence map›Paper›PMID 30864026›Full record

ArticleJournal of industrial microbiology & biotechnology2019

Production of medium chain length polyhydroxyalkanoate from acetate by engineered Pseudomonas putida KT2440.

Songyuan Yang, Suhang Li, Xiaoqiang Jia

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  3. Article
  4. Article
  5. Metabolic Engineering ofACS synthetic biology · 2025
    Article
  6. UpgradingACS omega · 2025
    Article
  7. Review
  8. 3 Biotech · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Perspectives for Using COBioengineering (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Review
  15. Tuning a high performing multiplexed-CRISPRiMetabolic engineering communications · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Songyuan YangDepartment of Biological Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, People's Republic of China.
Suhang LiDepartment of Biological Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, People's Republic of China.
Xiaoqiang JiaDepartment of Biological Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, People's Republic of China. xqjia@tju.edu.cn.ORCID http://orcid.org/0000-0002-1756-1926
Tianjin University · CNCollaborative Innovation Center of Chemical Science and Engineering Tianjin · CN

Funding

National Basic Research Program of China 2014CB745100National Natural Science Foundation of China (CN) 21576197Tianjin Key Research & Development Program 16YFXTSF00460Tianjin Research Program of Application Foundation and Advanced Technology 18JCYBJC23500
6 · The paper itself

Abstract

Pseudomonas putida was metabolically engineered to produce medium chain length polyhydroxyalkanoate (mcl-PHA) from acetate, a promising carbon source to achieve cost-effective microbial processes. As acetate is known to be harmful to cell growth, P. putida KT2440 was screened from three Pseudomonas strains (P. putida KT2440, P. putida NBRC14164, and P. aeruginosa PH1) as the host with the highest tolerance to 10 g/L of acetate in the medium. Subsequently, P. putida KT2440 was engineered by amplifying the acetate assimilation pathway, including overexpression of the acs (encoding acetyl-CoA synthetase) route and construction of the ackA-pta (encoding acetate kinase-phosphotransacetylase) pathway. The acs overexpressing P. putida KT2440 showed a remarkable increase of mcl-PHA titer (+ 92%), mcl-PHA yield (+ 50%), and cellular mcl-PHA content (+ 43%) compared with the wild-type P. putida KT2440, which indicated that acetate could be a potential substrate for biochemical production of mcl-PHA by engineered P. putida.

Indexed as

AcetatesBacterial ProteinsBatch Cell Culture TechniquesMetabolic EngineeringPolyhydroxyalkanoatesPseudomonas putidaAcetatesBacterial ProteinsPolyhydroxyalkanoatesAcetateMedium chain length polyhydroxyalkanoatePseudomonas putida KT2440

Identifiers

PMID30864026
OpenAlexW2922252081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.